Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.

By K. Abe, M. Aoki, S. Tsuji, Y. Itoyama, G. Sobue, Masanori Togo, C. Hamada, Masahiko Tanaka, M. Akimoto, Kazue Nakamura and 54 more. Lancet Neurology, 2017

730 citations recorded by the source corpus.

Subfields: Cellular and Molecular Neuroscience, Genetics, Neurology

View Paper: https://www.semanticscholar.org/paper/cf067724b899d53135f97497749eb57c0ea61e95